semaglutide patent expiry us China's weight-loss drug makers take on global giants as Novo Nordisk expires Massive Rs 50,000 Cr Opportunity

Filed Under: Biologics, Dermatology, Immunology, Infectious Disease, Metabolic disease/endicrinology, Oncology Tagged With: AbbVie, biologic drugs, biosimilar competition, drug sales H1 2025, Eli Lilly, GLP-1 drugs, IL-23 inhibitors, immunology drugs, Keytruda patent expiry, loss of exclusivity, Merck, Novo Nordisk, obesity drugs, Oncology Therapeutics, patent cliff 2028, PD-1 inhibitors, pharmaceutical blockbusters, prescription drug market, Skyrizi, therapeutic categories Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology

By nourishing the gut lining, L-Glutamine supports optimal digestion, immune function, and overall gastrointestinal well-being

Thc hin cc hot ng ny t 150-300 pht mi tun, tc 30-60 pht mi ngy, c th t chy calo d tha, ci thin tun hon mu v tng cng sc khe tim mch, ng thi h tr gim cn bn vng

Monore DH, Eaton DL

Salve tins are compact, durable, and easy to include in your travel toiletries